# Complete minimal protocol for testing edge cases
name: Complete Minimal
version: 1.0.0
author: Test Suite
description: Complete minimal protocol with all required fields for testing
protocol_type: treat_and_extend

# Disease states and transitions
disease_states:
  - name: NAIVE
    description: "Treatment naive"
  - name: STABLE
    description: "Stable disease"
  - name: ACTIVE
    description: "Active disease"
  - name: HIGHLY_ACTIVE
    description: "Highly active disease"

disease_transitions:
  NAIVE:
    NAIVE: 0.0
    STABLE: 0.8
    ACTIVE: 0.2
    HIGHLY_ACTIVE: 0.0
  STABLE:
    NAIVE: 0.0
    STABLE: 0.9
    ACTIVE: 0.1
    HIGHLY_ACTIVE: 0.0
  ACTIVE:
    NAIVE: 0.0
    STABLE: 0.3
    ACTIVE: 0.6
    HIGHLY_ACTIVE: 0.1
  HIGHLY_ACTIVE:
    NAIVE: 0.0
    STABLE: 0.0
    ACTIVE: 0.3
    HIGHLY_ACTIVE: 0.7

treatment_effect_on_transitions:
  NAIVE:
    NAIVE: 0.0
    STABLE: 0.9
    ACTIVE: 0.1
    HIGHLY_ACTIVE: 0.0
  STABLE:
    NAIVE: 0.0
    STABLE: 0.95
    ACTIVE: 0.05
    HIGHLY_ACTIVE: 0.0
  ACTIVE:
    NAIVE: 0.0
    STABLE: 0.7
    ACTIVE: 0.3
    HIGHLY_ACTIVE: 0.0
  HIGHLY_ACTIVE:
    NAIVE: 0.0
    STABLE: 0.0
    ACTIVE: 0.5
    HIGHLY_ACTIVE: 0.5

# Vision change model
vision_change_model:
  naive_treated:
    mean: 2.0
    std: 1.0
  naive_untreated:
    mean: -2.0
    std: 1.0
  stable_treated:
    mean: 0.5
    std: 0.5
  stable_untreated:
    mean: -1.0
    std: 0.5
  active_treated:
    mean: -1.0
    std: 1.0
  active_untreated:
    mean: -3.0
    std: 1.0
  highly_active_treated:
    mean: -2.0
    std: 1.5
  highly_active_untreated:
    mean: -5.0
    std: 2.0

# Treatment intervals
min_interval_days: 28
max_interval_days: 112
extension_days: 14
shortening_days: 14

# Baseline vision parameters
baseline_vision:
  mean: 70
  std: 10
  min: 20
  max: 85

# Other required parameters
max_injections_per_year: 13
loading_doses: 3

# Discontinuation rules
discontinuation_rules:
  poor_vision_threshold: 20
  poor_vision_probability: 0.1
  high_injection_count: 20
  high_injection_probability: 0.02
  long_treatment_months: 36
  long_treatment_probability: 0.01
  discontinuation_types:
    - planned
    - adverse
    - ineffective